{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:10:55Z","timestamp":1791213055757,"version":"4.1.0"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"DOI":"10.1093\/brain\/awh453","type":"journal-article","created":{"date-parts":[[2005,3,3]],"date-time":"2005-03-03T01:18:15Z","timestamp":1109812695000},"page":"988-1002","source":"Crossref","is-referenced-by-count":293,"title":["Intrathecal activation of the IL-17\/IL-8 axis in opticospinal multiple sclerosis"],"prefix":"10.1093","volume":"128","author":[{"given":"Takaaki","family":"Ishizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Osoegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Jun","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Takakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motozumi","family":"Minohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futoshi","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Taniwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Kira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,3,2]]},"reference":[{"key":"key\n\t\t\t\t20171011095446_B1","doi-asserted-by":"crossref","unstructured":"Aarvak T, Chabaud M, Miossec P, Natvig JB. IL-17 is produced by some proinflammatory Th1\/Th0 cells but not by Th2 cells. J Immunol1999; 162: 1246\u201351.","DOI":"10.4049\/jimmunol.162.3.1246"},{"key":"key\n\t\t\t\t20171011095446_B2","doi-asserted-by":"crossref","unstructured":"Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem2003; 278: 1910\u20134.","DOI":"10.1074\/jbc.M207577200"},{"key":"key\n\t\t\t\t20171011095446_B3","doi-asserted-by":"crossref","unstructured":"Becher B, Durell BG, Noelle RJ. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. J Clin Invest2003; 112: 1186\u201391.","DOI":"10.1172\/JCI200319079"},{"key":"key\n\t\t\t\t20171011095446_B4","doi-asserted-by":"crossref","unstructured":"Comabella M, Imitola J, Weiner HL, Khoury SJ. Interferon-beta treatment alters peripheral blood monocytes chemokine production in MS patients. J Neuroimmunol2002; 126: 205\u201312.","DOI":"10.1016\/S0165-5728(02)00064-4"},{"key":"key\n\t\t\t\t20171011095446_B5","doi-asserted-by":"crossref","unstructured":"Cree BA, Goodin DS, Hauser SL. Neuromyelitis optica. Semin Neurol2002; 22: 105\u201322.","DOI":"10.1055\/s-2002-36534"},{"key":"key\n\t\t\t\t20171011095446_B6","doi-asserted-by":"crossref","unstructured":"Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature2003; 421: 744\u20138.","DOI":"10.1038\/nature01355"},{"key":"key\n\t\t\t\t20171011095446_B7","doi-asserted-by":"crossref","unstructured":"de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol2003; 10: 133\u20139.","DOI":"10.1128\/CDLI.10.1.133-139.2003"},{"key":"key\n\t\t\t\t20171011095446_B8","doi-asserted-by":"crossref","unstructured":"Drulovic J, Mostarica-Stojkovic M, Levic Z, Stojsavljevic N, Pravica V, Mesaros S. Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients. J Neurol Sci1997; 147: 145\u201350.","DOI":"10.1016\/S0022-510X(96)05320-8"},{"key":"key\n\t\t\t\t20171011095446_B9","doi-asserted-by":"crossref","unstructured":"Dudler J, Renggli-Zulliger N, Busso N, Lotz M, So A. Effect of interleukin 17 on proteoglycan degradation in murine knee joints. Ann Rheum Dis2000; 59: 529\u201332.","DOI":"10.1136\/ard.59.7.529"},{"key":"key\n\t\t\t\t20171011095446_B10","doi-asserted-by":"crossref","unstructured":"Fassbender K, Ragoschke A, Rossol S, Schwartz A, Mielke O, Paulig A, et al. Increased release of interleukin-12p40 in MS: association with intracerebral inflammation. Neurology1998; 51: 753\u20138.","DOI":"10.1212\/WNL.51.3.753"},{"key":"key\n\t\t\t\t20171011095446_B11","doi-asserted-by":"crossref","unstructured":"Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med1996; 183: 2593\u2013603.","DOI":"10.1084\/jem.183.6.2593"},{"key":"key\n\t\t\t\t20171011095446_B12","doi-asserted-by":"crossref","unstructured":"Franciotta D, Martino G, Zardini E, Furlan R, Bergamaschi R, Andreoni L, et al. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J Neuroimmunol2001; 115: 192\u20138.","DOI":"10.1016\/S0165-5728(01)00261-2"},{"key":"key\n\t\t\t\t20171011095446_B13","doi-asserted-by":"crossref","unstructured":"Genain CP, Hauser SL. Allergic encephalomyelitis in common marmosets: pathogenesis of a multiple sclerosis-like lesion. Methods1996; 10: 420\u201334.","DOI":"10.1006\/meth.1996.0120"},{"key":"key\n\t\t\t\t20171011095446_B14","doi-asserted-by":"crossref","unstructured":"Hemmer B, Cepok S, Nessler S, Sommer N. Pathogenesis of multiple sclerosis: an update on immunology. Curr Opin Neurol2002; 15: 227\u201331.","DOI":"10.1097\/00019052-200206000-00001"},{"key":"key\n\t\t\t\t20171011095446_B15","doi-asserted-by":"crossref","unstructured":"Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol2002; 72: 847\u201355.","DOI":"10.1189\/jlb.72.5.847"},{"key":"key\n\t\t\t\t20171011095446_B16","doi-asserted-by":"crossref","unstructured":"Horiuchi I, Kawano Y, Yamasaki K, Minohara M, Furue M, Taniwaki T, et al. Th1 dominance in HAM\/TSP and the optico-spinal form of multiple sclerosis versus Th2 dominance in mite antigen-specific IgE myelitis. J Neurol Sci2000; 172: 17\u201324.","DOI":"10.1016\/S0022-510X(99)00232-4"},{"key":"key\n\t\t\t\t20171011095446_B17","doi-asserted-by":"crossref","unstructured":"Hoshino H, Laan M, Sjostrand M, Lotvall J, Skoogh BE, Linden A. Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. J Allergy Clin Immunol2000; 105: 143\u20139.","DOI":"10.1016\/S0091-6749(00)90189-1"},{"key":"key\n\t\t\t\t20171011095446_B18","doi-asserted-by":"crossref","unstructured":"Huang WX, Huang P, Link H, Hillert J. Cytokine analysis in multiple sclerosis by competitive RT\u2013PCR: a decreased expression of IL-10 and an increased expression of TNF-alpha in chronic progression. Mult Scler1999; 5: 342\u20138.","DOI":"10.1177\/135245859900500507"},{"key":"key\n\t\t\t\t20171011095446_B19","doi-asserted-by":"crossref","unstructured":"Hwang SY, Kim JY, Kim KW, Park MK, Moon Y, Kim WU, et al. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase\/Akt-dependent pathways. Arthritis Res Ther2004; 6: R120\u20138.","DOI":"10.1186\/ar1038"},{"key":"key\n\t\t\t\t20171011095446_B20","unstructured":"Ikuta F, Koga M, Takeda S, Ohama E, Takeshita I, Ogawa H, et al. Comparison of MS pathology between 70 American and 75 Japanese autopsy cases. In: Kuroiwa Y, Kurland LT, editors. Multiple sclerosis East and West. Fukuoka: Kyushu University Press; 1982. p. 298\u2013306."},{"key":"key\n\t\t\t\t20171011095446_B21","doi-asserted-by":"crossref","unstructured":"Jalonen TO, Pulkkinen K, Ukkonen M, Saarela M, Elovaara I. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes. J Neurol2002; 249: 576\u201383.","DOI":"10.1007\/s004150200067"},{"key":"key\n\t\t\t\t20171011095446_B22","doi-asserted-by":"crossref","unstructured":"Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry2001; 45: 27\u201336.","DOI":"10.1002\/1097-0320(20010901)45:1<27::AID-CYTO1141>3.0.CO;2-I"},{"key":"key\n\t\t\t\t20171011095446_B23","doi-asserted-by":"crossref","unstructured":"Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol2003; 2: 117\u201327.","DOI":"10.1016\/S1474-4422(03)00308-9"},{"key":"key\n\t\t\t\t20171011095446_B24","doi-asserted-by":"crossref","unstructured":"Kira J, Kanai T, Nishimura Y, Yamasaki K, Matsushita S, Kawano Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol1996; 40; 569\u201374.","DOI":"10.1002\/ana.410400405"},{"key":"key\n\t\t\t\t20171011095446_B25","doi-asserted-by":"crossref","unstructured":"Kleine TO, Zwerenz P, Graser C, Zofel P. Approach to discriminate subgroups in multiple sclerosis with cerebrospinal fluid (CSF) basic inflammation indices and TNF-alpha, IL-1beta, IL-6, IL-8. Brain Res Bull2003; 61: 327\u201346.","DOI":"10.1016\/S0361-9230(03)00096-0"},{"key":"key\n\t\t\t\t20171011095446_B26","doi-asserted-by":"crossref","unstructured":"Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest1999; 103: 1345\u201352.","DOI":"10.1172\/JCI5703"},{"key":"key\n\t\t\t\t20171011095446_B27","doi-asserted-by":"crossref","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983; 33: 1444\u201352.","DOI":"10.1212\/WNL.33.11.1444"},{"key":"key\n\t\t\t\t20171011095446_B28","doi-asserted-by":"crossref","unstructured":"Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol1999; 162: 2347\u201352.","DOI":"10.4049\/jimmunol.162.4.2347"},{"key":"key\n\t\t\t\t20171011095446_B29","doi-asserted-by":"crossref","unstructured":"Lafaille JJ, Keere FV, Hsu AL, Baron JL, Haas W, Raine CS, et al. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med1997; 186: 307\u201312.","DOI":"10.1084\/jem.186.2.307"},{"key":"key\n\t\t\t\t20171011095446_B30","doi-asserted-by":"crossref","unstructured":"Laman JD, Thompson EJ, Kappos L. Balancing the Th1\/Th2 concept in multiple sclerosis. Immunol Today1998; 19: 489\u201390.","DOI":"10.1016\/S0167-5699(98)01320-6"},{"key":"key\n\t\t\t\t20171011095446_B31","doi-asserted-by":"crossref","unstructured":"Lassmann H, Ransohoff RM. The CD4-Th1 model for multiple sclerosis: a crucial re-appraisal. Trends Immunol2004; 25: 132\u20137.","DOI":"10.1016\/j.it.2004.01.007"},{"key":"key\n\t\t\t\t20171011095446_B32","doi-asserted-by":"crossref","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet2004; 364: 2106\u201312.","DOI":"10.1016\/S0140-6736(04)17551-X"},{"key":"key\n\t\t\t\t20171011095446_B33","doi-asserted-by":"crossref","unstructured":"Li YP, Pei YY, Zhou ZH, Zhang XY, Gu ZH, Ding J, et al. PEGylated recombinant human tumor necrosis factor alpha: pharmacokinetics and anti-tumor effects. Biol Pharm Bull2001; 24: 666\u201370.","DOI":"10.1248\/bpb.24.666"},{"key":"key\n\t\t\t\t20171011095446_B34","doi-asserted-by":"crossref","unstructured":"Linden A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol2001; 126: 179\u201384.","DOI":"10.1159\/000049511"},{"key":"key\n\t\t\t\t20171011095446_B35","doi-asserted-by":"crossref","unstructured":"Linden A, Adachi M. Neutrophilic airway inflammation and IL-17. Allergy2002; 57: 769\u201375.","DOI":"10.1034\/j.1398-9995.2002.02164.x"},{"key":"key\n\t\t\t\t20171011095446_B36","doi-asserted-by":"crossref","unstructured":"Link H. The cytokine storm in multiple sclerosis. Mult Scler1998; 4: 12\u20135.","DOI":"10.1177\/135245859800400104"},{"key":"key\n\t\t\t\t20171011095446_B37","doi-asserted-by":"crossref","unstructured":"Link J, Soderstrom M, Olsson T, Hojeberg B, Ljungdahl A, Link H. Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis. Ann Neurol1994; 36: 379\u201386.","DOI":"10.1002\/ana.410360309"},{"key":"key\n\t\t\t\t20171011095446_B38","doi-asserted-by":"crossref","unstructured":"Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med2002; 8: 500\u20138.","DOI":"10.1038\/nm0502-500"},{"key":"key\n\t\t\t\t20171011095446_B39","doi-asserted-by":"crossref","unstructured":"Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain2002; 125: 1450\u201361.","DOI":"10.1093\/brain\/awf151"},{"key":"key\n\t\t\t\t20171011095446_B40","unstructured":"Mahad DJ, Howell SJ, Woodroofe MN. Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry2002; 72: 498\u2013502."},{"key":"key\n\t\t\t\t20171011095446_B41","doi-asserted-by":"crossref","unstructured":"Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredrikson S, et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler1999; 5: 101\u20134.","DOI":"10.1177\/135245859900500206"},{"key":"key\n\t\t\t\t20171011095446_B42","doi-asserted-by":"crossref","unstructured":"Matusevicius D, Navikas V, Soderstrom M, Xiao BG, Haglund M, Fredrikson S, et al. Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells. J Neuroimmunol1996; 66: 115\u201323.","DOI":"10.1016\/0165-5728(96)00032-X"},{"key":"key\n\t\t\t\t20171011095446_B43","doi-asserted-by":"crossref","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50: 121\u20137.","DOI":"10.1002\/ana.1032"},{"key":"key\n\t\t\t\t20171011095446_B44","doi-asserted-by":"crossref","unstructured":"Minohara M, Ochi H, Matsushita S, Irie A, Nishimura Y, Kira J. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls. Tissue Antigens2001; 57: 447\u201356.","DOI":"10.1034\/j.1399-0039.2001.057005447.x"},{"key":"key\n\t\t\t\t20171011095446_B45","doi-asserted-by":"crossref","unstructured":"Miossec P. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum2003; 48: 594\u2013601.","DOI":"10.1002\/art.10816"},{"key":"key\n\t\t\t\t20171011095446_B46","doi-asserted-by":"crossref","unstructured":"Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J, Linden A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol2003; 170: 4665\u201372.","DOI":"10.4049\/jimmunol.170.9.4665"},{"key":"key\n\t\t\t\t20171011095446_B47","doi-asserted-by":"crossref","unstructured":"Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol2001; 108: 430\u20138.","DOI":"10.1067\/mai.2001.117929"},{"key":"key\n\t\t\t\t20171011095446_B48","doi-asserted-by":"crossref","unstructured":"Monteyne P, Van Laere V, Marichal R, Sindic CJ. Cytokine mRNA expression in CSF and peripheral blood mononuclear cells in multiple sclerosis: detection by RT\u2013PCR without in vitro stimulation. J Neuroimmunol1997; 80: 137\u201342.","DOI":"10.1016\/S0165-5728(97)00148-3"},{"key":"key\n\t\t\t\t20171011095446_B49","doi-asserted-by":"crossref","unstructured":"Navikas V, Link H. Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res1996; 45: 322\u201333.","DOI":"10.1002\/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B"},{"key":"key\n\t\t\t\t20171011095446_B50","doi-asserted-by":"crossref","unstructured":"Navikas V, He B, Link J, Haglund M, Soderstrom M, Fredrikson S, et al. Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. Brain1996; 119: 213\u201323.","DOI":"10.1093\/brain\/119.1.213"},{"key":"key\n\t\t\t\t20171011095446_B51","doi-asserted-by":"crossref","unstructured":"Niino M, Ogata A, Kikuchi S, Tashiro K, Nishihira J. Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behcet's disease. J Neurol Sci2000; 179: 127\u201331.","DOI":"10.1016\/S0022-510X(00)00397-X"},{"key":"key\n\t\t\t\t20171011095446_B52","doi-asserted-by":"crossref","unstructured":"Ochi H, Wu XM, Osoegawa M, Horiuchi I, Minohara M, Murai H, et al. Tc1\/Tc2 and Th1\/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy\/tropical spastic paraparesis and hyperIgEaemic myelitis. J Neuroimmunol2001; 119: 297\u2013305.","DOI":"10.1016\/S0165-5728(01)00393-9"},{"key":"key\n\t\t\t\t20171011095446_B53","doi-asserted-by":"crossref","unstructured":"Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev1995; 144: 245\u201368.","DOI":"10.1111\/j.1600-065X.1995.tb00072.x"},{"key":"key\n\t\t\t\t20171011095446_B54","doi-asserted-by":"crossref","unstructured":"Panitch HS, Hirsch RL, Haley AS, Johnson KP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet1987; 1: 893\u20135.","DOI":"10.1016\/S0140-6736(87)92863-7"},{"key":"key\n\t\t\t\t20171011095446_B55","doi-asserted-by":"crossref","unstructured":"Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, et al. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology1994; 44: 1523\u20136.","DOI":"10.1212\/WNL.44.8.1523"},{"key":"key\n\t\t\t\t20171011095446_B56","doi-asserted-by":"crossref","unstructured":"Saruhan-Direskeneli G, Yentur SP, Akman-Demir G, Isik N, Serdaroglu P. Cytokines and chemokines in neuro-Behcet's disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol2003; 145: 127\u201334.","DOI":"10.1016\/j.jneuroim.2003.08.040"},{"key":"key\n\t\t\t\t20171011095446_B57","doi-asserted-by":"crossref","unstructured":"Scarpini E, Galimberti D, Baron P, Clerici R, Ronzoni M, Conti G, et al. IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease. J Neurol Sci2002; 195: 41\u20136.","DOI":"10.1016\/S0022-510X(01)00680-3"},{"key":"key\n\t\t\t\t20171011095446_B58","doi-asserted-by":"crossref","unstructured":"Sharief MK, Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med1991; 325: 467\u201372.","DOI":"10.1056\/NEJM199108153250704"},{"key":"key\n\t\t\t\t20171011095446_B59","doi-asserted-by":"crossref","unstructured":"Sharief MK, Thompson EJ. Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis. J Neurol Neurosurg Psychiatry1993; 56: 169\u201374.","DOI":"10.1136\/jnnp.56.2.169"},{"key":"key\n\t\t\t\t20171011095446_B60","unstructured":"Shiraki H. Neuropathological findings of demyelinating encephalomyelitides of unknown etiology in Japan. Saishin Igaku1965; 20: 1036\u201352."},{"key":"key\n\t\t\t\t20171011095446_B61","doi-asserted-by":"crossref","unstructured":"Stefferl A, Brehm U, Storch M, Lambracht-Washington D, Bourquin C, Wonigeit K, et al. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the \u2018resistant\u2019 Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J Immunol1999; 163: 40\u20139.","DOI":"10.4049\/jimmunol.163.1.40"},{"key":"key\n\t\t\t\t20171011095446_B62","doi-asserted-by":"crossref","unstructured":"Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M, et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol1998; 8: 681\u201394.","DOI":"10.1111\/j.1750-3639.1998.tb00194.x"},{"key":"key\n\t\t\t\t20171011095446_B63","doi-asserted-by":"crossref","unstructured":"St\u00fcrzebecher S, Wandinger KP, Rosenwald A, Sathyamoorthy M, Tzou A, Mattar P, et al. Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis. Brain2003; 126: 1419\u201329.","DOI":"10.1093\/brain\/awg147"},{"key":"key\n\t\t\t\t20171011095446_B64","doi-asserted-by":"crossref","unstructured":"S\u00f8rensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest1999; 103: 807\u201315.","DOI":"10.1172\/JCI5150"},{"key":"key\n\t\t\t\t20171011095446_B65","doi-asserted-by":"crossref","unstructured":"S\u00f8rensen TL, Trebst C, Kivisakk P, Klaege KL, Majmudar A, Ravid R, et al. Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system. J Neuroimmunol2002; 127: 59\u201368.","DOI":"10.1016\/S0165-5728(02)00097-8"},{"key":"key\n\t\t\t\t20171011095446_B66","doi-asserted-by":"crossref","unstructured":"Tabira T, Tateishi J. Neuropathological features of MS in Japan. In: Kuroiwa Y, Kurland LT, editors. Multiple sclerosis East and West. Fukuoka: Kyushu University Press; 1982. p. 273\u201395.","DOI":"10.1159\/000408050"},{"key":"key\n\t\t\t\t20171011095446_B67","doi-asserted-by":"crossref","unstructured":"Trebst C, Ransohoff RM. Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges. Arch Neurol2001; 58: 1975\u201380.","DOI":"10.1001\/archneur.58.12.1975"},{"key":"key\n\t\t\t\t20171011095446_B68","doi-asserted-by":"crossref","unstructured":"van Boxel-Dezaire AH, Hoff SC, van Oosten BW, Verweij CL, Drager AM, Ader HJ, et al. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann Neurol1999; 45: 695\u2013703.","DOI":"10.1002\/1531-8249(199906)45:6<695::AID-ANA3>3.0.CO;2-R"},{"key":"key\n\t\t\t\t20171011095446_B69","doi-asserted-by":"crossref","unstructured":"Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods2000; 243: 243\u201355.","DOI":"10.1016\/S0022-1759(00)00238-6"},{"key":"key\n\t\t\t\t20171011095446_B70","doi-asserted-by":"crossref","unstructured":"Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology1999; 53: 1107\u201314.","DOI":"10.1212\/WNL.53.5.1107"},{"key":"key\n\t\t\t\t20171011095446_B71","doi-asserted-by":"crossref","unstructured":"Witowski J, Ksiazek K, Jorres A. Interleukin-17: a mediator of inflammatory responses. Cell Mol Life Sci2004; 61: 567\u201379.","DOI":"10.1007\/s00018-003-3228-z"},{"key":"key\n\t\t\t\t20171011095446_B72","doi-asserted-by":"crossref","unstructured":"Wu XM, Osoegawa M, Yamasaki K, Kawano Y, Ochi H, Horiuchi I, et al. Flow cytometric differentiation of Asian and Western types of multiple sclerosis, HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cell subsets. J Neurol Sci2000; 177: 24\u201331.","DOI":"10.1016\/S0022-510X(00)00322-1"},{"key":"key\n\t\t\t\t20171011095446_B73","doi-asserted-by":"crossref","unstructured":"Yamasaki K, Horiuchi I, Minohara M, Kawano Y, Ohyagi Y, Yamada T, et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain1999; 122: 1689\u201396.","DOI":"10.1093\/brain\/122.9.1689"},{"key":"key\n\t\t\t\t20171011095446_B74","doi-asserted-by":"crossref","unstructured":"Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol2000; 164: 2832\u20138.","DOI":"10.4049\/jimmunol.164.5.2832"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/128\/5\/988\/780752\/awh453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T14:47:41Z","timestamp":1683038861000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/brain\/article\/128\/5\/988\/278464\/Intrathecal-activation-of-the-IL17IL8-axis-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,2]]},"references-count":74,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,3,2]]},"published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awh453","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,5]]},"published":{"date-parts":[[2005,3,2]]}}}